SubsidiaryJun 23, 2026, 07:42 AM
Trinity Biotech Launches Trinovium for AI Data Center Cooling
AI Summary
Trinity Biotech plc announced the launch of Trinovium, a new subsidiary dedicated to advanced liquid cooling solutions and fluid intelligence systems for AI data centers. Trinovium will leverage Trinity's existing expertise in ultra-high-purity fluid manufacturing, analytical technologies, and large-scale production capabilities. This move targets the rapidly growing data center liquid cooling market, projected to expand from $4 billion in 2026 to $27 billion by 2033, driven by increasing AI compute density. The initiative aims to provide a capital-efficient path into this market and create potential for additional operating leverage from existing assets.
Key Highlights
- Trinity Biotech launched Trinovium, a new subsidiary.
- Trinovium focuses on advanced liquid cooling solutions for AI data centers.
- Leverages Trinity's expertise in ultra-high-purity fluid manufacturing and analytical technologies.
- Data center liquid cooling market projected to grow from $4 billion in 2026 to $27 billion by 2033.
- Trinovium will offer a direct-to-chip liquid cooling formulation.
- Developing a fluid health and system intelligence platform for recurring revenue.
Price Impact
More from TRIB